Actinic Keratosis Market Segmentation, Application Analysis and Market Forecast

Posted by akshayparmar on November 17th, 2017

Actinic Keratosis Market (Liquid Nitrogen Cryotherapy, Surgical Therapy, 5-aminolevulinic acid (ALA), Methyl Aminolevulinate (MAL), 5-fluorouracil, Imiquimod, Ingenol Mebutate, Diclofenac Sodium, Chemical Peels and Others) - Growth, Future Prospects and Competitive Analysis, 2017-2025, the actinic keratosis market was valued at USD 6,847.2 Mn in 2016 and is expected to reach USD 9,416.1 Mn by 2025, with the market progressing at a CAGR 4.35%from 2017-2025.

 View Full Report with TOC @


 Market Insights

Actinic keratosis (AK) is characterized by skin papules, macules or plaques resulting from prolonged exposure to harmful UV exposure and can result in squamous cell carcinoma. Risk of developing actinic keratosis increases with advancing age and is particularly higher in men as against women. About 5-20% of patients with actinic keratosis lesions develop malignant and potentially fatal squamous cell carcinomas.

North America is the largest market for actinic keratosis treatment due to growing prevalence of AK, better public awareness about occurrence of AK and associated risk of squamous cell carcinoma. According to American Academy of Dermatology (AAD), approximately 60% of the Americans aged 40 year or above, Actinic Keratosis is predisposed to develop having at least 1 AK lesion. Actinic keratosis is precursors of squamous cell cancer. 

This market is majorly driven by wide presence of generic drugs and is moderately competitive. Photodynamic therapy market has developed a niche with methyl aminolevulinate and aminolevulinic acid drugs. Galderma and DUSA pharmaceuticals are the chief players in this space. Some of the major players in the global actinic keratosis market are Tolmar Pharmaceuticals, Inc, DUSA Pharmaceuticals, Inc., Valeant Pharmaceuticals International, Inc., Aqua Pharmaceuticals, LLC, Galderma SA, Perrigo Company plc, LEO Laboratories, Apotex and others."


"Chapter 1 Preface
1.1 Report Description
1.1.1 Purpose of the Report
1.1.2 Target Audience
1.1.3 USP and Key Offerings
1.2 Research Scope
1.3 Research Methodology

Chapter 2 Executive Summary
2.1 Global Actinic Keratosis Market Revenue, by Treatment, 2015, (US$ Mn)
2.2 Global Actinic Keratosis Market Revenue, by Geography, 2015, (USD Million)

Chapter 6 Company Profiles
6.1 Tolmar Pharmaceuticals, Inc.
6.1.1 Tolmar Pharmaceuticals, Inc.: Company Snapshot (Business Description; Financial Health and Budget Allocation; Product Position/Portfolio; News Coverage)
6.2 DUSA Pharmaceuticals, Inc. (Sun Pharma)
6.2.1 DUSA Pharmaceuticals, Inc. (Sun Pharma): Company Snapshot (Business Description; Financial Health and Budget Allocation; Product Position/Portfolio; News Coverage)
6.3 Valeant Pharmaceuticals International, Inc.
6.3.1 Valeant Pharmaceuticals International, Inc.: Company Snapshot (Business Description; Financial Health and Budget Allocation; Product Position/Portfolio; News Coverage)
6.4 Aqua Pharmaceuticals, LLC


About - Acute Market Reports :
Acute Market Reports is the most sufficient collection of market intelligence services online. It is your only source that can fulfill all your market research requirements. We provide online reports from over 100 best publishers and upgrade our collection regularly to offer you direct online access to the world’s most comprehensive and recent database with expert perceptions on worldwide industries, products, establishments and trends.

Our team consists of highly motivated market research professionals and they are accountable for creating the groundbreaking technology that we utilize in our search engine operations to easily recognize the most current market research reports online.

Contact Us :

Name : Chris Paul


Designation : Global Sales Manager

Toll Free(US/CANADA): +1-855-455-8662

Email :

Website :

Like it? Share it!


About the Author

Joined: July 31st, 2017
Articles Posted: 1,226

More by this author